Concepedia

Jeremy L. Clark

JL

Statistics

Publications

8

Citations

452

H-Index

8

Active since

1970

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Southern Research Institute

Emory University

Jeremy L. Clark is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in molecular virology, antiviral pharmacology, and medicinal chemistry.

Publications per year

1970–2012

8

Publications

8

Design, Synthesis, and Antiviral Activity of 2‘-Deoxy-2‘-fluoro-2‘-<i>C</i>-methylcytidine, a Potent Inhibitor of Hepatitis C Virus Replication

Jeremy L. Clark, Laurent Hollecker, Joan Mason et al. · Journal of Medicinal Chemistry · 2005 · 198 citations

, , +17

Inhibition of Hepatitis C Replicon RNA Synthesis by β-D-2′-deoxy-2′-fluoro-2′-<i>C</i>-Methylcytidine: A Specific Inhibitor of Hepatitis C Virus Replication

Lieven Stuyver, Tamara R. McBrayer, Phillip M. Tharnish et al. · Antiviral chemistry & chemotherapy · 2006 · 119 citations

, , +17

Synthesis and antiviral activity of 2′-deoxy-2′-fluoro-2′-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication

Jeremy L. Clark, Joan Mason, Laurent Hollecker et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 59 citations

, , +16

Inhibitors of the IMPDH Enzyme as Potential Anti-Bovine Viral Diarrhoea Virus Agents

Lieven Stuyver, Stefania Lostia, Steven Patterson et al. · Antiviral chemistry & chemotherapy · 2002 · 26 citations · Full text

, , +16

5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors

Ashok Arasappan, Frank Bennett, Vinay Girijavallabhan et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 15 citations

, , +14

1–5 of 8